$0.97
0.066[7.30%]
At close: Apr 19
$0.97
0[0.00%]
After Hours: 7:08AM EDT
Mainz Biomed
(NASDAQ:MYNZ)Mainz Biomed Stock (NASDAQ:MYNZ), Analyst Ratings, Price Targets, Predictions
Mainz Biomed NV has a consensus price target of $4.67, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, HC Wainwright & Co., and Cantor Fitzgerald on April 12, 2024, March 6, 2024, and November 21, 2023. With an average price target of $1 between Cantor Fitzgerald, HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 3.09% upside for Mainz Biomed NV from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
JonesTrading
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Mainz Biomed
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | MYNZ | Buy Now | Mainz Biomed | $0.97 | — | Cantor Fitzgerald | Ross Osborn | — | Reiterates | → Neutral | Get Alert |
| 03/06/2024 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 209.28% | HC Wainwright & Co. | Yi Chen | $5 → $3 | Maintains | Buy | Get Alert |
| 11/21/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | — | Cantor Fitzgerald | Ross Osborn | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/20/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 415.46% | HC Wainwright & Co. | Yi Chen | $9 → $5 | Maintains | Buy | Get Alert |
| 09/26/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 827.84% | Cantor Fitzgerald | Ross Osborn | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 09/22/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 827.84% | HC Wainwright & Co. | Yi Chen | $7 → $9 | Maintains | Buy | Get Alert |
| 09/14/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 827.84% | Cantor Fitzgerald | Ross Osborn | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 827.84% | Cantor Fitzgerald | Ross Osborn | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 08/18/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 621.65% | HC Wainwright & Co. | Yi Chen | $10 → $7 | Reiterates | Buy → Buy | Get Alert |
| 06/01/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 930.93% | HC Wainwright & Co. | Yi Chen | → $10 | Reiterates | → Buy | Get Alert |
| 05/18/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 1137.11% | Cantor Fitzgerald | Ross Osborn | $15 → $12 | Maintains | Overweight | Get Alert |
| 04/27/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 930.93% | HC Wainwright & Co. | Yi Chen | $25 → $10 | Maintains | Buy | Get Alert |
| 03/30/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 2477.32% | HC Wainwright & Co. | Yi Chen | → $25 | Reiterates | → Buy | Get Alert |
| 02/16/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 2477.32% | HC Wainwright & Co. | Yi Chen | → $25 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 1034.02% | JonesTrading | Justin Walsh | → $11 | Initiates | → Buy | Get Alert |
| 10/25/2022 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 1446.39% | Cantor Fitzgerald | Ross Osborn | → $15 | Initiates | → Overweight | Get Alert |
| 06/21/2022 | MYNZ | Buy Now | Mainz Biomed | $0.97 | 2477.32% | HC Wainwright & Co. | Yi Chen | → $25 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Mainz Biomed (MYNZ)?
The latest price target for Mainz Biomed (NASDAQ: MYNZ) was reported by Cantor Fitzgerald on April 12, 2024. The analyst firm set a price target for $0.00 expecting MYNZ to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mainz Biomed (MYNZ)?
The latest analyst rating for Mainz Biomed (NASDAQ: MYNZ) was provided by Cantor Fitzgerald, and Mainz Biomed reiterated their neutral rating.
When was the last upgrade for Mainz Biomed (MYNZ)?
There is no last upgrade for Mainz Biomed.
When was the last downgrade for Mainz Biomed (MYNZ)?
The last downgrade for Mainz Biomed NV happened on November 21, 2023 when Cantor Fitzgerald changed their price target from N/A to N/A for Mainz Biomed NV.
When is the next analyst rating going to be posted or updated for Mainz Biomed (MYNZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mainz Biomed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mainz Biomed was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating Mainz Biomed (MYNZ) correct?
While ratings are subjective and will change, the latest Mainz Biomed (MYNZ) rating was a reiterated with a price target of $0.00 to $0.00. The current price Mainz Biomed (MYNZ) is trading at is $0.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.